πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 311 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 7632510

Methods of inducing flavivirus immune responses through the administration of recombinant

The United States of America as represtented by the Secretary of the Department of Health and Human Services, Centers for Disease Control and Prevention Β· Granted Tue Dec 15 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 10 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7622107

Recombinant intracellular pathogen immunogenic compositions and methods for use

The Regents of the University of California Β· Granted Tue Nov 24 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 19 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7604968

Microorganisms for the recombinant production of resveratrol and other flavonoids

Regents of the University of Minnesota Β· Granted Tue Oct 20 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 15 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7563883

Recombinant P. falciparum merozoite protein-142 vaccine

The United States of America as represented by the Secretary of the Army Β· Granted Tue Jul 21 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 16 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7553931

Complement depletion using recombinant human C3-derivatives

PLS-Design GmbH Β· Granted Tue Jun 30 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 25 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7544778

Recombinant antigens for diagnosis and prevention of murine typhus

United States of America as represented by the Secretary of the Air Force Β· Granted Tue Jun 09 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 04 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7541034

Recombinant antibodies and immunoconjugates targeted to CD-22 bearing cells and tumors

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Jun 02 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 28 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7541139

Tryptophan as a functional replacement for ADP-ribose-arginine in recombinant proteins

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Jun 02 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 28 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7524507

Recombinant microorganisms

The Secretary of State for Defence in Her Brittanic Majesty's Government of the United Kingdom of Great Britain and Northern Ireland Β· Granted Tue Apr 28 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 23 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7521177

Flavivirus detection methods employing recombinant antigens comprising a Japanese encephal

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Apr 21 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 16 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7465794

Polynucleotides encoding recombinant respiratory syncytial viruses expressing immune modul

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Dec 16 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 11 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7446182

Recombinant antibodies for the detection and neutralization of anthrax toxin

The Board of Regents of the University of Texas System Β· Granted Tue Nov 04 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 30 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7410644

Recombinant pox virus for immunization against tumor-associated antigens

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Aug 12 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 07 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7371571

Recombinant mycobacteria overexpressing D-alanine ligase gene and uses therefore

BOARD OF REGENTS UNIVERSITY OF NEBRASKA-LINCOLN Β· Granted Tue May 13 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 08 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7361356

Self-assembling recombinant papillomavirus capsid proteins

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Apr 22 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 17 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7354576

Methods of treating diseases caused by deficiencies of recombinant Ξ±-L-iduronidase

BIOMARIN PHARMACEUTICAL INC. Β· Granted Tue Apr 08 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 03 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7335477

Truncated recombinant major outer membrane protein antigen (r56) of Orientia tsutsugamushi

United States of America as represented by the Secretary of the Air Force Β· Granted Tue Feb 26 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 21 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7314631

Use of recombinant live-attenuated parainfluenza virus (PIV) as a vector to protect agains

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Jan 01 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 27 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7306808

Orientia tsutsugamushi truncated recombinant outer membrane protein (r47) and (r57) vaccin

United States of America as represented by the Secretary of the Air Force Β· Granted Tue Dec 11 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 06 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7306806

Recombinant P. falciparum merozoite protein-142 vaccine

The United States of America as represented by the Secretary of the Army Β· Granted Tue Dec 11 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 06 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7265215

DNA or RNA encoding a recombinant dengue envelope protein

The United States of America as represented by the Secretary of the Army Β· Granted Tue Sep 04 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 30 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7261900

Recombinant modified Bacillus anthracis protective antigen for use in vaccines

The United States of America as Represented by the Secretary of the Department of Health and Human Services Β· Granted Tue Aug 28 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 23 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7256281

Recombinant P. falciparum merozoite protein-142 vaccine

The United States of America as represented by the Secretary of the Army Β· Granted Tue Aug 14 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 09 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7250171

Construction and use of recombinant parainfluenza viruses expressing a chimeric glycoprote

The United States of America as represented by the Secretary of the Dept. of Health & Human Services Β· Granted Tue Jul 31 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 26 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted